Disease: Juvenile pilocytic astrocytoma
- A comparison study of dynamic [<sup>18</sup>F]Alfatide II imaging and [<sup>11</sup>C]MET in orthotopic rat models of glioblastoma
- A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy
- A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians
- A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases
- Anti-epileptic drug use during adjuvant chemo-radiotherapy is associated with poorer survival in patients with glioblastoma: A nationwide population-based cohort study
- Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes
- Antitumoral Activity of the Universal Methyl Donor <em>S</em>-Adenosylmethionine in Glioblastoma Cells
- Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With <em>IDH1/2</em>-Mutant Lower-Grade Glioma
- Automatic brain-tumor diagnosis using cascaded deep convolutional neural networks with symmetric U-Net and asymmetric residual-blocks
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker
- BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion
- Calcified cystic lesion in cerebellum: A case report
- Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas
- Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling
- Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma
- Comparison of MRI findings of hypothalamic-optic chiasmatic gliomas and craniopharyngiomas
- D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study
- Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases
- Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors
- Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients
- Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes
- DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers
- Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence
- Endoplasmic Reticulum Stress in Gliomas: Exploiting a Dual-Effect Dysfunction through Chemical Pharmaceutical Compounds and Natural Derivatives for Therapeutical Uses
- Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages
- Estrogen α and β Receptor Expression in the Various Regions of Resected Glioblastoma Multiforme Tumors and in an In Vitro Model
- Exploring fetal brain tumor glioblastoma symptom verification with self organizing maps and vulnerability data analysis
- Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients
- First parechovirus reported case in Saudi Arabia in hospitalized immunocompromised adult patient
- Focal-to-bilateral tonic-clonic seizures and High-grade CMV-infection are poor survival predictors in Tumor-related Epilepsy Adult-type diffuse gliomas-A single-center study and literature review
- Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases
- Gene Expression Patterns Associated with Survival in Glioblastoma
- Giant Retinal Astrocytoma: A Case Report of an Uncommon Presentation of Tuberous Sclerosis in a Young Female
- Glioblastoma mechanobiology at multiple length scales
- Grading of glioma tumors using digital holographic microscopy
- Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study
- ID1<sup>high</sup>/activin A<sup>high</sup> glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature
- Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors
- Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma
- Inhibition of signaling protein ERN1 increases the sensitivity of serine synthesis gene expressions to glucose and glutamine deprivations in U87MG glioblastoma cells
- Interrater Agreement of BT-RADS for Evaluation of Follow-Up MRI in Treated Primary Brain Tumor Patients
- Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes
- Juvenile pilocytic astrocytoma in a child with a prior normal neonatal brain MRI
- Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis
- Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?
- Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy
- Mesenchymal-Stem-Cell-Based Therapy against Gliomas
- Metastases and Primary Brain Tumors Affecting the Fornix of the Brain
- Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors
- MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma
- Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging
- Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades
- Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations
- New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy
- New Insights into Glioblastoma
- Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion
- Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma
- Pilocytic astrocytoma with KRAS gene mutation: a clinicopathological analysis of two cases
- Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma
- Predicting Isocitrate Dehydrogenase Status in Non-Contrast-Enhanced Adult-Type Astrocytic Tumors Using Diffusion Tensor Imaging and <sup>11</sup>C-Methionine, <sup>11</sup>C-Choline, and <sup>18</sup>F-Fluorodeoxyglucos
- Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms
- Principles in the Management of Glioblastoma
- PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway
- Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma
- Prognostic Value of ATRX and p53 Status in High-Grade Glioma Patients in Morocco
- Radio-anatomical evaluation of clinical and radiomic profile of multi-parametric magnetic resonance imaging of de novo glioblastoma multiforme
- Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma
- RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma
- Rare vermian pilocytic astrocytoma with recurrent spontaneous hemorrhage in the elderly: A case report and review of literature
- Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas
- Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma Cells
- Role of sodium fluorescein in pediatric low-grade glioma surgery: an update
- ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM
- SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)
- Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis
- Single is not combined: The role of Co and Ni bioavailability on toxicity mechanisms in liver and brain cells
- Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
- Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family
- SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201)
- Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification
- Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics
- Synergistic Effect of a Combination of Proteasome and Ribonucleotide Reductase Inhibitors in a Biochemical Model of the Yeast <em>Saccharomyces cerevisiae</em> and a Glioblastoma Cell Line
- TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
- Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
- The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2
- The implications of machine learning in predicting glioblastoma recurrence: a correspondence
- The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells
- The RAS oncogene in brain tumors and the involvement of let-7 microRNA
- The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma
- The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index
- The Spectrum of Central Nervous System Tumors at a Tertiary Care Center Primarily Serving a Rural Population
- Three recent breakthroughs in CAR T cells for the treatment of glioblastoma: Is it the light at the end of the tunnel?
- Trans-Sylvian and Transanterior Ascending Ramus Approach for Insular Gliomas at Zone I: 2-Dimensional Operative Video
- Transmembrane Protein TMEM230, Regulator of Glial Cell Vascular Mimicry and Endothelial Cell Angiogenesis in High-Grade Heterogeneous Infiltrating Gliomas and Glioblastoma
- Two-headed UNetEfficientNets for parallel execution of segmentation and classification of brain tumors: incorporating postprocessing techniques with connected component labelling
- USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization
- VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
- Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy